News

NanoGroup S.A. is launching the next phase of research with a proprietary innovative organ perfusion fluid
07.02.2023

NanoGroup S.A. is launching the next phase of research with a proprietary innovative organ perfusion fluid

After announcing positive results from preliminary studies comparing kidneys perfused with NanOX 10 and NanOX 20 fluids with the current standard used in t…

NanoGroup S.A. continues advanced works on an innovative organ perfusion fluid and device
26.01.2023

NanoGroup S.A. continues advanced works on an innovative organ perfusion fluid and device

For 18 years now, January 26 has been the National Transplantation Day. Transplantation is one of the areas close to NanoGroup S.A.’s business. The c…

NanoVelos SA in pharmaceutical industry report
16.12.2022

NanoVelos SA in pharmaceutical industry report

We are in “Report on pharmaceutical and cosmetics industry in Warsaw “. The publication includes. Information on projects i…

Przemyslaw Mazurek joins the team and becomes CEO.
30.11.2022

Przemyslaw Mazurek joins the team and becomes CEO.

We are pleased to announce that Przemyslaw Mazurek has joined NanoGroup to take on the role of CEO. He knows the Company quite well fro…

Founder’s risky move to raise funds
21.10.2022

Founder’s risky move to raise funds

“What we need most is money and time, because we are developing our own scientific projects that require a number of studies, that’s …

US research firm tests NanoVelos’s formulation
10.10.2022

US research firm tests NanoVelos’s formulation

A research report by Certis Oncology Solutions Inc. from the U.S. (“CERTIS”) on a Polish oncology drug candidate indicate that P…

pp-thumbnail